Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,271 | -83,838 | -60,887 | -39,652 | -20,468 |
| Depreciation Amortization | -1,142 | 751 | 1,154 | 1,042 | 602 |
| Other Working Capital | 7,133 | -1,335 | 1,575 | 1,260 | 1,359 |
| Other Operating Activity | 4,678 | 13,651 | 10,236 | 6,577 | 2,929 |
| Operating Cash Flow | $-18,602 | $-70,771 | $-47,922 | $-30,773 | $-15,578 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -37,878 | -190,856 | -112,718 | -72,241 | -6,055 |
| PPE Investments | -759 | -845 | -796 | -715 | -149 |
| Purchase Of Investment | 63,945 | 146,211 | 109,294 | 86,335 | 30,041 |
| Investing Cash Flow | $25,308 | $-45,490 | $-4,220 | $13,379 | $23,837 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 116 | 131,180 | 55,821 | 50,570 | 132 |
| Financing Cash Flow | $116 | $131,180 | $55,821 | $50,570 | $132 |
| Beginning Cash Position | 38,946 | 24,027 | 24,027 | 24,027 | 24,027 |
| End Cash Position | 45,768 | 38,946 | 27,706 | 57,203 | 32,418 |
| Net Cash Flow | $6,822 | $14,919 | $3,679 | $33,176 | $8,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,602 | -70,771 | -47,922 | -30,773 | -15,578 |
| Capital Expenditure | -759 | -845 | -796 | -715 | -149 |
| Free Cash Flow | -19,361 | -71,616 | -48,718 | -31,488 | -15,727 |